Published in Ann Dermatol Venereol on February 25, 2010
[Is there really a need for the classification "Eosinophilic dermatitis of blood disorders"?]. Ann Dermatol Venereol (2010) 0.75
Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol (1991) 3.29
Problems performing a sciatic nerve block in an amputee. Anaesthesia (2003) 3.23
Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol (1999) 2.34
Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther (2008) 1.92
Chronic radiodermatitis following cardiac catheterisation: a report of two cases and a brief review of the literature. Heart (1999) 1.78
Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol (1999) 1.77
Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol (1998) 1.70
Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol (2014) 1.66
A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients. Leukemia (2004) 1.63
Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome). Diabetes Metab (2005) 1.44
[Haematopoietic stem cell transplantation in the treatment of autoimmune diseases]. Rev Med Interne (2007) 1.42
Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation. J Clin Oncol (2000) 1.39
Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study. Ann Oncol (2014) 1.39
Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab. Leukemia (2007) 1.35
Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer (2000) 1.29
[Difficulties in diagnosis of human dirofilariasis outside known enzootic areas]. Rev Med Interne (2002) 1.28
Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol (1996) 1.23
Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases. Dermatology (2010) 1.19
Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans. Br J Dermatol (2005) 1.19
Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol (2000) 1.15
Paediatric mastocytosis: a systematic review of 1747 cases. Br J Dermatol (2015) 1.13
Study of the B cell memory compartment in common variable immunodeficiency. Eur J Immunol (2000) 1.09
High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol (1998) 1.08
Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis. Bone Marrow Transplant (2005) 1.07
[Low-molecular-weight heparin-induced bullous haemorrhagic dermatosis associated with cell-mediated hypersensitivity]. Ann Dermatol Venereol (2009) 1.03
Efficacy of bendamustine in relapsed/refractory myeloma patients: results from the French compassionate use program. Leuk Lymphoma (2011) 1.02
[The Thyroid Imaging Reporting and Data System (TIRADS) for ultrasound of the thyroid]. J Radiol (2011) 1.00
Lhermitte-Duclos disease and Cowden's syndrome. Report of two cases. Neurochirurgie (2006) 1.00
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience. Leukemia (2011) 0.99
Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer (2000) 0.98
Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study. J Clin Pathol (2003) 0.97
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera. Dermatology (2004) 0.95
First-line autologous stem cell transplantation in primary CNS lymphoma. Eur J Haematol (2005) 0.94
Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases. Respiration (2007) 0.94
Testicular fibroma of gonadal stromal origin with minor sex cord elements: clinicopathologic and immunohistochemical study of 2 cases. Arch Pathol Lab Med (1999) 0.93
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol (2011) 0.92
[Topical silver sulfadiazine-induced acute renal failure]. Ann Dermatol Venereol (2005) 0.92
[Adenoid cystic carcinoma of the breast]. Cancer Radiother (2009) 0.91
Venous leg ulcer: a meta-analysis of adjunctive therapy with micronized purified flavonoid fraction. Eur J Vasc Endovasc Surg (2005) 0.91
Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation. Transplantation (2002) 0.89
Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia (2006) 0.89
Two atypical cases of cutaneous gamma/delta T-cell lymphomas. Dermatology (2011) 0.88
[Comparison of the individual deprivation index of the French Health Examination Centres and the administrative definition of deprivation]. Sante Publique (2006) 0.88
Malignant melanoma and granulomatosis. Br J Dermatol (1997) 0.87
Myelofibrosis-associated lymphoproliferative disease: retrospective study of 16 cases and literature review. Adv Hematol (2009) 0.86
Colorectal carcinoma with potentially resectable metastases: factors associated with the failure of curative schedule. Gastroenterol Clin Biol (2008) 0.85
Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study. Br J Dermatol (2012) 0.85
Visceral Kaposi's sarcoma associated with human herpesvirus 8 seroconversion in a heart transplant recipient. Transplant Proc (2004) 0.85
Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome. Bone Marrow Transplant (2004) 0.84
Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization. Bone Marrow Transplant (2000) 0.84
[Digestive oncology: surgical practices]. J Chir (Paris) (2009) 0.84
[Non-differentiated carcinoma with osteoclast-like giant cells of the pancreas: a case report]. Cancer Radiother (2006) 0.84
Contribution of PTEN large rearrangements in Cowden disease: a multiplex amplifiable probe hybridisation (MAPH) screening approach. J Med Genet (2008) 0.83
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases. Leukemia (2009) 0.83
[Gelatinous transformation of the bone marrow. A rare cause of pancytopenia in a cachectic patient with a past history of oeso-gastrectomy and colectomy]. Gastroenterol Clin Biol (2008) 0.83
Choroidal detachment induced by dorzolamide 20 years after cataract surgery. Br J Ophthalmol (2002) 0.83
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM. Ann Hematol (2013) 0.82
Comment to: Borch-Johnsen K, Colagiuri S, Balkau B et al. (2004) Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47:1396-1402. Diabetologia (2005) 0.82
Thalidomide therapy induces response in relapsed mantle cell lymphoma. Leukemia (2003) 0.82
Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma. Cancer Chemother Pharmacol (2014) 0.82
Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome. Br J Cancer (2009) 0.82
Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA. Ann Oncol (2013) 0.82
[Alopecia areata during anti-TNF alpha therapy: Nine cases]. Ann Dermatol Venereol (2011) 0.82
[Gallbladder cancer revealed by a jaundice caused by an endobiliary tumor thrombus]. Ann Chir (2004) 0.82
Letter: A case of generalized guttate psoriasis induced by etanercept with relapse after abatacept. Dermatol Online J (2011) 0.81
[Incidence of cardiovascular events in giant cell arteritis: preliminary results of a prospective double cohort study (GRACG)]. Rev Med Interne (2005) 0.81
[North African and Southeast Asian nasopharyngeal carcinomas: between the resemblance and the dissemblance]. Bull Cancer (2010) 0.81
Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancer. Ann Oncol (2012) 0.81
Inhibition of mouse mast cell proliferation and proinflammatory mediator release by benzodiazepines. Immunopharmacology (1999) 0.81
Risk factors for yeast superinfection in the treatment of suspected exit site infections: a case-control study. J Vasc Access (2008) 0.80
[Evolution of the thyroid surgical treatment to the total thyroidectomy. Study of about 735 patients]. Ann Otolaryngol Chir Cervicofac (2005) 0.80
[Mouth ulcers induced by enteric-coated mycophenolate sodium (Myfortic]. Ann Dermatol Venereol (2007) 0.80
Multiple splenic nodules revealing Gaucher's disease. Histopathology (2002) 0.80
Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study. Rheumatology (Oxford) (2008) 0.80
Oropharyngeal and hypopharyngeal myxoma: case report and literature review. J Laryngol Otol (2007) 0.80
Febrile ulceronecrotic Mucha-Habermann disease: treatment with infliximab and intravenous immunoglobulins and review of the literature. Dermatology (2013) 0.79
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation. Bone Marrow Transplant (2004) 0.79
CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness. Int J Lab Hematol (2011) 0.79
The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients. Bone Marrow Transplant (2006) 0.79
Gastric metastases. An endoscopic series of ten cases. Gastroenterol Clin Biol (2010) 0.79
Severe cardiac toxicity after monoclonal antibody therapy. Eur J Haematol (2002) 0.79